New Zealand's Pharmac has announced that from 1 November, it will expand access to Merck's ERBITUX (cetuximab) for bowel cancer, bendamustine for blood cancer, and pemetrexed. …
Latest Video
New Stories
-
The industry faces significant uncertainty, with barely three weeks until the US election
October 14, 2024 - - Latest News -
TGA signs Memorandum of Understanding with South Africa's regulator
October 14, 2024 - - Latest News -
Dementia set to become Australia’s leading cause of death
October 13, 2024 - - Latest News -
Pharmac announces expanded access to three cancer medicines
October 11, 2024 - - Latest News -
Novartis-led partnership says heart health shouldn't be dependent on where you live
October 11, 2024 - - Latest News -
Bondi Junction response must include increased funding and support for severe mental illness
October 11, 2024 - - Latest News -
New report unveils hidden cost of Alzheimer’s disease, with cases to double by 2050
October 10, 2024 - - Latest News